European Medicines Agency starts review of Pandemrix
Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report
Two-Thirds Respond to "Re-vaccination "
Clients in focus...
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us